Healthcare / Health Information ServicesASX
$0.14
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 10%
FCF escenarios
weak_data · normalized FCF $-1.3M · quality 22.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$50M
P/E
13.5x
↓EV/EBITDA
11.8x
↓ROE
113.3%
↑Gross Margin
43.2%
↓Debt/Equity
9.04
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+8.4%
FCF CAGR
—
FCF margin
6.8%
FCF / Net income
2.25x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $38.0M · net income $1.2M · FCF $2.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $38.0M | $38.0M | $39.3M | $38.5M | $29.8M |
| Net Income | $1.2M | $1.2M | $-6.3M | $-10.0M | $-22.0M |
| EBITDA | $4.4M | $4.4M | $-2.1M | $-8.4M | $-22.2M |
| EPS | — | — | -0.02 | -0.03 | -0.06 |
| Gross Margin | 43.2% | 43.2% | 57.0% | 46.0% | 42.9% |
| Operating Margin | -2.0% | -2.0% | -18.1% | -22.7% | -67.8% |
| Net Margin | 3.0% | 3.0% | -16.0% | -26.1% | -74.0% |
| Balance Sheet | |||||
| Debt/Equity | 9.04 | 9.04 | -12.50 | 4.63 | — |
| Current Ratio | 1.55 | 1.55 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.6M | $2.6M | $-1.3M | $-8.7M | $-17.6M |
| Returns | |||||
| ROE | 113.3% | 113.3% | 975.3% | -430.9% | -179.3% |
| Valuation | |||||
| P/E | 13.50 | 13.50 | — | — | — |
| EV/EBITDA | 11.85 | 11.85 | — | — | — |
| P/B | 48.59 | 48.59 | — | 12.07 | 1.55 |
| Growth & Yield | |||||
| Revenue Growth | -3.4% | -3.4% | 2.3% | 29.1% | — |
| EPS Growth | — | — | 33.3% | 50.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+22.7%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.02 → n/d
Residual
+22.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.